Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Image Scan gets first order for new ThreatScan system

(Sharecast News) - Security and industrial screening specialist Image Scan announced an initial order worth £0.3m from a partner on Monday, for the supply of 'ThreatScan-AS1' portable x-ray systems as part of a framework contract secured by the partner with a European Ministry of Defence organisation. The AIM-traded form said the order, scheduled for delivery in the second half of the 2024 financial year, was a significant milestone, as it was the first substantial order for the ThreatScan-AS1.

While further orders were anticipated throughout the partner's two-year framework contract, the exact volume and timing remained uncertain.

However, Image Scan said the initial order was expected to meet its expectations for the year ending 30 September.

The board said the framework contract's implementation was not anticipated to impact its working capital requirements.

"We are thrilled to announce this initial order, it marks a major step forward in positioning our portable x-ray product line and underscores the strength of our international sales and marketing efforts," said chief executive officer Vince Deery.

"We are confident that the superior capabilities of our new systems will resonate with other customers globally."

At 0952 BST, shares in Image Scan Holdings were up 16.33% at 1.4p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.